EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Berberine Alleviates Lipopolysaccharide-Induced Acute Lung Injury by Modulating the AMPK-HMGB1-NF-κB Signaling Axis

Tingxia Lv, Chunpan Zhang, Yawei Zeng, Lan Hu, Guangwei Huang, Chao Wang, Wenjie Qi

Frontiers in Bioscience-Landmark · 2026

DOI: 10.31083/fbl45524 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Bioscience-Landmark, 2026. Verfasst von Tingxia Lv und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Disease, Beijing Friendship Hospital, Capital Medical University, 100050 Beijing, China. Hauptthemen laut MEDLINE: Berberine, Acute Lung Injury, HMGB1 Protein, NF-kappa B. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: High-level Public Health Technology Talent Construction Project, National key clinical specialty construction Project (2022) & University, Capital Medical University Natural Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The activation of adenosine-monophosphate-activated protein kinase (AMPK) by berberine (BBR) benefits various inflammatory diseases. Conversely, high mobility group box-1 (HMGB1), a prototypical damage-associated molecular pattern (DAMP), typically exerts opposing effects. This research aims to investigate the relationship between AMPK and HMGB1, elucidating the functions and underlying mechanisms by which BBR alleviates acute lung injury (ALI) caused by lipopolysaccharide (LPS).

Methods

Male C57BL/6J mice were intragastrically administered BBR twice daily for three days with a total of 25 and 100 mg/kg/day. On day four, an intraperitoneal injection of 10 mg/kg LPS was administered, and BBR was given two hours before and six hours after this injection, respectively. Eighteen hours post-LPS administration, lung tissues and serum samples were collected to assess indicators of lung tissue injury, inflammation, oxidative stress, and apoptosis. The relationship between AMPK activation, HMGB1 release, and inflammatory activation was investigated in both mice and RAW264.7 cells using protein expression analysis, AMPK silencing, and exogenous HMGB1 introduction.

Results

Our findings demonstrate that BBR activates AMPK and inhibits HMGB1 expression, translocation, and release in LPS-induced ALI, resulting in reduced histopathological lung injuries, decreased expression of inflammatory cytokine genes, and diminished oxidative stress and apoptosis. Mechanistic studies revealed that BBR decreases extracellular HMGB1 in LPS-stimulated RAW264.7 cells and inhibits HMGB1-stimulated nuclear factor Kappa B (NF-κB) activation. Concurrently, silencing the activation of AMPK by siRNA and compound C reversed the BBR-reduced extracellular HMGB1 level in LPS-stimulated RAW264.7 cells.

Conclusions

Based on these findings, we conclude that BBR effectively inhibits inflammation, oxidative stress, and apoptosis in LPS-induced ALI by modulating the AMPK-HMGB1-NF-κB axis. Consequently, BBR and other AMPK activators may represent promising therapeutic options for managing systemic inflammation and injury during sepsis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BerberineAcute Lung InjuryHMGB1 ProteinNF-kappa BSignal TransductionAMP-Activated Protein KinasesAnimalsLipopolysaccharidesMaleMiceMice, Inbred C57BLRAW 264.7 CellsOxidative StressApoptosisLung

Stichwörter der Autor:innen

AMP-activated protein kinaseHMGB1 proteinacute lung injuryberberinesepsis

Substanzen

BerberineHMGB1 ProteinLipopolysaccharidesNF-kappa BAMP-Activated Protein KinasesHMGB1 protein, mouse

Autor:innen und Institutionen

  • Department of Infectious Disease, Beijing Friendship Hospital, Capital Medical University, 100050 Beijing, China.

Förderung

  • High-level Public Health Technology Talent Construction Project
  • National key clinical specialty construction Project (2022) & University
  • Capital Medical University Natural Science Foundation

Zitieren

APA

Lv, T., Zhang, C., Zeng, Y., Hu, L., Huang, G., Wang, C., & Qi, W. (2026). Berberine Alleviates Lipopolysaccharide-Induced Acute Lung Injury by Modulating the AMPK-HMGB1-NF-κB Signaling Axis. Frontiers in Bioscience-Landmark. https://doi.org/10.31083/fbl45524

Vancouver

Lv T, Zhang C, Zeng Y, Hu L, Huang G, Wang C, et al. Berberine Alleviates Lipopolysaccharide-Induced Acute Lung Injury by Modulating the AMPK-HMGB1-NF-κB Signaling Axis. Frontiers in Bioscience-Landmark. 2026. doi:10.31083/fbl45524

BibTeX
@article{Lv2026,
  author = {Lv, Tingxia and Zhang, Chunpan and Zeng, Yawei and Hu, Lan and Huang, Guangwei and Wang, Chao and Qi, Wenjie},
  title = {Berberine Alleviates Lipopolysaccharide-Induced Acute Lung Injury by Modulating the AMPK-HMGB1-NF-κB Signaling Axis},
  journal = {Frontiers in Bioscience-Landmark},
  year = {2026},
  doi = {10.31083/fbl45524}
}
Kostenlos starten →